SCHEMBL1907986

SCHEMBL1907986

C#Cc1ccc2nc(Nc3cc(OC[C@@H](C)NC(=O)CN(C)C)cc(-c4cn[nH]c4)c3)ncc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K5 Q99683 2/20 0.42
▸ BRAF P15056 12/20 0.34
▸ ACACB O00763 1/20 0.34
▸ MAP4K1 Q92918 2/20 0.33
▸ ROCK2 O75116 2/20 0.32
▸ DYRK3 O43781 1/20 0.32
▸ PRKD3 O94806 1/20 0.32
▸ PRKCG P05129 1/20 0.32
▸ LCK P06239 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ PIM1 P11309 1/20 0.32
▸ PRKACA P17612 1/20 0.32
▸ RPS6KB1 P23443 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ AKT1 P31749 1/20 0.32
▸ AKT2 P31751 1/20 0.32
▸ FLT4 P35916 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ MAPK8 P45983 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1907985 1.00 MAP3K5 (0.42) MAP3K5BRAFACACBMAP4K1ROCK2
SCHEMBL1572760 0.87 FGFR1 (0.36) BRAFACACBMAP4K1KDR
SCHEMBL1572761 0.87 FGFR1 (0.36) BRAFACACBMAP4K1KDR
SCHEMBL1571733 0.77 BRAF (0.39) BRAFACACBMAP4K1
SCHEMBL1571735 0.77 BRAF (0.39) BRAFACACBMAP4K1
SCHEMBL3504879 0.77 MAP3K5 (0.66) MAP3K5BRAFMAP4K1ROCK2DYRK1A
SCHEMBL13336150 0.73 BRAF (0.39) BRAF
SCHEMBL1573464 0.72 MAP4K1 (0.38) BRAFMAP4K1CDK2KDRMAPK8
SCHEMBL1571415 0.72 MAP4K1 (0.38) BRAFMAP4K1CDK2KDRMAPK8
SCHEMBL1571784 0.69 MAP4K1 (0.38) ACACBMAP4K1CDK2FLT4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079988-A9 QUINAZOLINES FOR PDK1 INHIBITION NOVARTIS AG (CH) 2011-05-12 — — WO disclosed
Send feedback